Thursday, April 07, 2022 9:42:24 PM
AGN has gone past that milestone on ALL it's programs with murine testing (etc) and proof of concept/MOA enough to start New ones and move forward with other Human Clinical trials.
Pretty much a 'when' and 'which' question.
When that is set I hope for a much better PPS and leverage for raising money/IPO/2+ for 1...liquidity.?.
Second Phase 2 clinical trial data due.
So far.
A Full Plate for the next couple years.
A fair Speculative investment, IMO. I am holding. Every one has the Right to 'opine' their crystal balls...
...GLTA...
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM